Publications

• Spree Bar, a vaping system delivering a synthetic nicotine analogue, marketed in the USA as 'PMTA exempt'.Jordt SE, Jabba SV, Zettler PJ, Berman ML. Tob Control. 2025 May 15; 2025 May 15. PMID: 38499343.
• Including the term 'tobacco-free nicotine' in the nicotine addiction warning label mandated by the US Food and Drug Administration alters risk perceptions and use intentions.Morean ME, Gueorguieva R, O'Malley S, Krishnan-Sarin S. Tob Control. 2025 Apr 1; 2025 Apr 1. PMID: 37898544.
• Development and Psychometric Evaluation of a Novel Measure of Nicotine E-cigarette Withdrawal for Use With Adolescents and Young Adults.Morean ME, Rajeshkumar L, Krishnan-Sarin S. Nicotine Tob Res. 2024 Nov 22. PMID: 38695371.
• Impact of vanilla flavor on nicotine taste, choice, intake, and seeking behaviors.Bagdas D, Zepei AM, Harris L, Minanov K, Jimenez JL, Addy NA. Psychopharmacology (Berl). 2024 Nov; 2024 Jun 6. PMID: 38839631.
• A Review of the Toxicity of Ingredients in e-Cigarettes, Including Those Ingredients Having the FDA's "Generally Recognized as Safe (GRAS)" Regulatory Status for Use in Food.Kassem NOF, Strongin RM, Stroup AM, Brinkman MC, El-Hellani A, Erythropel HC, Etemadi A, Exil V, Goniewicz ML, Kassem NO, Klupinski TP, Liles S, Muthumalage T, Noël A, Peyton DH, Wang Q, Rahman I, Valerio LG Jr. Nicotine Tob Res. 2024 Oct 22. PMID: 38783714.
• Behavioral Precursors of Nicotine Product Use Trajectories Among Youth.Buta E, Gueorguieva R, Simon P, Garrison KA. Am J Prev Med. 2024 Sep; 2024 May 21. PMID: 38782105.
• Responses to Real-World and Hypothetical E-Cigarette Flavor Bans Among US Young Adults Who Use Flavored E-Cigarettes.Tam J, Jimenez-Mendoza E, Buckell J, Sindelar J, Meza R. Nicotine Tob Res. 2024 Jul 22. PMID: 38141252.
• E-cigarette dependence and cooling flavor use are linked among youth.Li W, Davis DR, Kong G, Bold KW, Morean ME, Camenga D, Sharma A, Lee J, Krishnan-Sarin S. Drug Alcohol Depend. 2024 Jul 1; 2024 May 11. PMID: 38744108.
• Non-tobacco nicotine E-cigarette use and flavored E-cigarette use among young adults in the United States.Li W, Krishnan-Sarin S, Morean ME, Bold KW, Davis DR, Camenga DR, Kong G. Prev Med. 2024 Jul; 2024 May 11. PMID: 38735588.
• The Scientific Basis for the Regulation of Flavors in Tobacco Products.Bold KW, Kong G, O'Malley SS. Annu Rev Clin Psychol. 2024 Jul; 2024 Jul 2. PMID: 38346292.
• Characteristics of Adolescents' and Young Adults' Exposure to and Engagement with Nicotine and Tobacco Product Content on Social Media.Vogel EA, Ranker LR, Harrell PT, Hart JL, Kong G, McIntosh S, Meissner HI, Ozga JE, Romer D, Stanton CA. J Health Commun. 2024 Jun 2; 2024 May 22. PMID: 38775659.
• Socioecological factors associated with multiple nicotine product use among U.S. youth: Findings from the population assessment of tobacco and health (PATH) study 2013-2018.Simon P, Stefanovics E, Ying S, Gueorguieva R, Krishnan-Sarin S, Buta E. Prev Med. 2024 Jun; 2024 Apr 13. PMID: 38615947.
• How healthcare providers and the right information may play a critical role in quitting success among smokers interested in using e-cigarettes for quitting: Results from a survey of U.S adults.Sharma A, King J, Krishnan-Sarin S, O'Malley SS, Morean M, Bold K. PLoS One. 2024; 2024 May 16. PMID: 38753868.
• Sources of exposure to non-tobacco nicotine electronic nicotine delivery systems and associations with susceptibility to use and use behaviors among young adults in the United States.Li W, Kong G, Davis DR, Bold KW, Krishnan-Sarin S, Camenga DR, Morean ME. PLoS One. 2024; 2024 May 8. PMID: 38718067.
• High Variability in Nicotine Analog Contents, Misleading Labeling, and Artificial Sweetener in New E-Cigarette Products Marketed as "FDA-Exempt".Erythropel HC, Jabba SV, Silinski P, Anastas PT, Krishnan-Sarin S, Zimmerman JB, Jordt SE. medRxiv. 2024 Apr 22; 2024 Apr 22. PMID: 38766027.
• Prioritizing Common Terminology and Measures to Advance Research on Oral Nicotine Product Use.Hrywna M, Ozga JE, Stanton CA, Chaffee BW, Delnevo CD, Fucito LM, Jabba SV, Morean ME, Tackett AP. Nicotine Tob Res. 2024 Apr 22. PMID: 37846819.
• Tobacco promotion restriction policies on social media.Kong G, Laestadius L, Vassey J, Majmundar A, Stroup AM, Meissner HI, Ben Taleb Z, Cruz TB, Emery SL, Romer D. Tob Control. 2024 Apr 19; 2024 Apr 19. PMID: 36328589.
• Comparison of emissions across tobacco products: A slippery slope in tobacco control.El-Hellani A, Adeniji A, Erythropel HC, Wang Q, Lamb T, Mikheev VB, Rahman I, Stepanov I, Strongin RM, Wagener TL, Brinkman MC. Tob Induc Dis. 2024; 2024 Mar 30. PMID: 38560551.
• Tobacco-free blunt wraps: a regulatory conundrum.Kong G, Morean ME, Davis DR, Bold KW, Krishnan-Sarin S. Tob Control. 2024 Mar 19; 2024 Mar 19. PMID: 37604696.
• A randomized controlled trial of potential tobacco policies prohibiting menthol flavor in cigarettes and e-cigarettes: a study protocol.Bold KW, Sharma A, Haeny A, Gueorguieva R, Buta E, Baldassarri S, Lempert L, Krishnan-Sarin S, O'Malley S. BMC Psychiatry. 2024 Mar 12; 2024 Mar 12. PMID: 38475757.
• Why young adults use tobacco-free nicotine E-cigarettes: An analysis of qualitative data.Davis DR, Rajesh Kumar L, Morean ME, Kong G, Bold KW, Krishnan-Sarin S, Camenga DE. Addict Behav. 2024 Mar; 2023 Nov 24. PMID: 38056193.
• Associations Between Childhood Trauma and Tobacco Use Outcomes in Adults after Overnight Abstinence.Palmisano AN, Schwartz EKC, Gueorguieva R, Sofuoglu M. Nicotine Tob Res. 2024 Feb 22. PMID: 37565294.
• Artificial Sweeteners in US-Marketed Oral Nicotine Pouch Products: Correlation with Nicotine Contents and Effects on Product Preference.Jabba SV, Silinski P, Yang AY, Ouyang W, Jordt SE. bioRxiv. 2024 Jan 27; 2024 Jan 27. PMID: 38328200.
• Tobacco 21 Laws and Youth Tobacco Use: The Role of Policy Attributes.Friedman AS, Pesko MF. Am J Public Health. 2024 Jan. PMID: 38091563.
• Content Analysis of YouTube Videos Related to E-Cigarettes and COVID-19.Lee J, Ouellette RR, Murthy D, Kong G. Subst Use Misuse. 2024; 2023 Dec 1. PMID: 37798867.
• Psychometric evaluation of the sensory e-cigarette expectancies scale for use with adolescents.Morean ME, Davis DR, Kong G, Bold KW, Krishnan-Sarin S. Addict Behav. 2024 Jan; 2023 Sep 23. PMID: 37778234.
• Emerging ENDS products and challenges in tobacco control toxicity research.Strongin RM, Sharma E, Erythropel HC, El-Hellani A, Kassem NOF, Mikheev VB, Noël A, Peyton DH, Springer ML. Tob Control. 2023 Dec 13; 2023 Dec 13. PMID: 35715171.
• Polysubstance use by sexual identity among US adults, 2021.Lee J, Evans-Polce RJ, Ahlquist J, Parker MA. Prev Med. 2023 Dec; 2023 Oct 16. PMID: 37852580.
• Association of racial discrimination in health care settings and use of electronic cigarettes to quit smoking among Black adults.Jackson AB, Gibbons FX, Fleischli ME, Haeny AM, Bold KW, Suttiratana SC, Fagan P, Krishnan-Sarin S, Gerrard M. J Subst Use Addict Treat. 2023 Dec; 2023 Feb 22. PMID: 36822270.
• England Is Handing out E-Cigarettes: Is the "Swap to Stop" Tobacco Control Scheme Harm Reduction or Harm Production?Lang AE, Kathuria H, Braillon A, Ewart G, Dagli E, Stepp EL, Galiatsatos P, Deepak J, Jordt SE, Hayes D Jr. Am J Respir Crit Care Med. 2023 Nov 15. PMID: 37682082.
• Synthetic Cooling Agent and Other Flavor Additives in "Non-Menthol" Cigarettes Marketed in California and Massachusetts After Menthol Cigarette Bans.Jabba SV, Erythropel HC, Anastas PT, Zimmerman JB, Jordt SE. JAMA. 2023 Nov 7. PMID: 37812408.
• How can I measure brain acetylcholine levels in vivo? Advantages and caveats of commonly used approaches.Mineur YS, Picciotto MR. J Neurochem. 2023 Oct; 2023 Aug 24. PMID: 37621094.
• Social media use and cannabis vaping initiation among US youth.Lee J, Krishnan-Sarin S, Kong G. Drug Alcohol Depend. 2023 Aug 1; 2023 Jun 1. PMID: 37290171.
• Accurately classifying cannabis blunt use as tobacco-cannabis co-use versus exclusive cannabis use.Morean ME, Kong G, Bold KW, Davis DR, Krishnan-Sarin S. Drug Alcohol Depend. 2023 Aug 1; 2023 May 21. PMID: 37270936.
• Tobacco use and cancer-related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study.Price SN, Palmer AM, Fucito LM, Graboyes EM, Baker NL, Rojewski AM, Toll BA. Cancer. 2023 Aug 1; 2023 May 22. PMID: 37211959.
• Qualitative exploration of longer versus shorter quit attempts among adults using E-Cigarettes for combustible cigarette cessation.Suttiratana SC, Morean ME, Krishnan-Sarin S, Bold KW. Addict Behav. 2023 Aug; 2023 Mar 30. PMID: 37015170.
• Harm reduction for smokers with little to no quit interest: can tobacco policies encourage switching to e-cigarettes?Buckell J, Fucito LM, Krishnan-Sarin S, O'Malley S, Sindelar JL. Tob Control. 2023 Aug; 2022 Jan 19. PMID: 35046127.
• The Promotion of Premium Cigars on Social Media.Kong G, Lee J, Celentano M, Tang C, Geller A, Mead A, Landrum Sterling K. Nicotine Tob Res. 2023 Jul 28. PMID: 37506234.
• The Portrayal of Premium Cigar Selling Propositions in Lifestyle Magazines: A Content Analysis.Sterling KL, Franco N, Lee E, Tang C, Geller A, Mead A, Anderson M, Kong G. Nicotine Tob Res. 2023 Jul 28. PMID: 37506232.
• Synthetic Cooling Agent and Candy Flavors in California-marketed "non-Menthol" Cigarettes.Jabba SV, Erythropel HC, Anastas PT, Zimmerman JB, Jordt SE. bioRxiv. 2023 May 18; 2023 May 18. PMID: 37292602.
• Examining racial differences in smoking outcomes among smokers enrolled in an intravenous nicotine infusion study.Schwartz EKC, Palmisano AN, Gueorguieva R, DeVito EE, Sofuoglu M. Addict Behav. 2023 May; 2023 Jan 9. PMID: 36640662.
• E-cigarette Use Patterns, Flavors, and Device Characteristics Associated With Quitting Smoking Among a U.S. sample of Adults Using E-cigarettes in a Smoking Cessation Attempt.Bold K, O'Malley S, Krishnan-Sarin S, Morean M. Nicotine Tob Res. 2023 Apr 6. PMID: 36462196.
• Models for Zero-Inflated and Overdispersed Correlated Count Data: An Application to Cigarette Use.Pittman B, Buta E, Garrison K, Gueorguieva R. Nicotine Tob Res. 2023 Apr 6. PMID: 36318799.
• The first nicotine product tried is associated with current multiple nicotine product use and nicotine dependence among a nationally representative sample of U.S. youths.Simon P, Buta E, Jackson A, Camenga DR, Kong G, Morean ME, Bold KW, Davis DR, Krishnan-Sarin S, Gueorguieva R. Prev Med. 2023 Apr; 2023 Jan 30. PMID: 36731754.
• The interactive effects of JUUL flavor and nicotine concentration on addiction potential.Peasley-Miklus C, Klemperer EM, Hughes JR, Villanti AC, Krishnan-Sarin S, DeSarno MJ, Mosca LA, Su A, Cassidy RN, Feinstein MJP. Exp Clin Psychopharmacol. 2023 Apr; 2022 Sep 1. PMID: 36048114.
• Synthetic nicotine has arrived.Jordt SE. Tob Control. 2023 Apr; 2021 Sep 7. PMID: 34493630.
• Association of Non-Cigarette Tobacco Advertisements and Racial Discrimination With Non-Cigarette Tobacco Product Use Among Black Adults.Jackson A, Fleischli ME, Haeny AM, Rose SW, Fagan P, Krishnan-Sarin S, Gerrard M, Gibbons FX. Nicotine Tob Res. 2023 Mar 22. PMID: 36169563.
• Sugars and Sweeteners in Tobacco and Nicotine Products: Food and Drug Administration's Regulatory Implications.Rezk-Hanna M, Talhout R, Jordt SE. Nicotine Tob Res. 2023 Mar 22. PMID: 36148496.
• Synthetic Cooling Agent in Oral Nicotine Pouch Products Marketed as "Flavor-Ban Approved".Jabba SV, Erythropel HC, Woodrow JG, Anastas PT, O'Malley SS, Krishnan-Sarin S, Zimmerman JB, Jordt SE. bioRxiv. 2023 Feb 24; 2023 Feb 24. PMID: 36865160.
• E-cigarette Marketing Expenditures in the United States From 2016 to 2021: Targeted Media Outlets Geared Toward People Who Are at Increased Risk for Tobacco Use.Ozga JE, Stroup AM, Abadi MH, Cheney MK, Majmundar A, Garrison KA, Chen-Sankey J, Shamblen S, Dunlap C, Stanton CA. Nicotine Tob Res. 2023 Feb 9. PMID: 36070398.
• Use and Product Characteristics of "Tobacco Free Nicotine" E-Cigarettes Among Young Adults.Davis DR, Bold KW, Camenga D, Kong G, Jackson A, Lee J, Rajesh-Kumar L, Krishnan-Sarin S, Morean ME. Nicotine Tob Res. 2023 Feb 9. PMID: 35913677.
• Threshold for the pleasurable effects of nicotine are lower than its reinforcing effects during self-administration.MacLean RR, Eid T, Parida S, Gueorguieva R, DeVito EE, Sofuoglu M. Exp Clin Psychopharmacol. 2023 Feb; 2022 Mar 7. PMID: 35254839.
• Awareness, susceptibility, and use of oral nicotine pouches and comparative risk perceptions with smokeless tobacco among young adults in the United States.Morean ME, Bold KW, Davis DR, Kong G, Krishnan-Sarin S, Camenga DR. PLoS One. 2023; 2023 Jan 30. PMID: 36716297.
• Chronic oral nicotine exposure decreases aversive taste of nicotine, increases nicotine withdrawal and reinstatement, but cherry flavor does not alter nicotine's effects in adolescent rats.Bagdas D, Harris L, Addy NA. Neurosci Lett. 2023 Jan 10; 2022 Dec 5. PMID: 36476758.
• Synthetic Nicotine: Science, Global Legal Landscape, and Regulatory Considerations.Berman ML, Zettler PJ, Jordt SE. World Health Organ Tech Rep Ser. 2023; 2023 Aug 23. PMID: 37745838.
• "Tobacco-free" Nicotine Pouches: Risk Perceptions, Awareness, Susceptibility, and Use Among Young Adults in the United States.Morean ME, Bold KW, Davis DR, Kong G, Krishnan-Sarin S, Camenga DR. Nicotine Tob Res. 2023 Jan 1. PMID: 36000776.
• Common Measures to Evaluate Flavored Tobacco Products: Recommendations From the Tobacco Centers for Regulatory Science (TCORS) Flavored Tobacco Products Measurement Subcommittee.Bansal-Travers M, Price SM, Bold KW, Villanti AC, Barnes A, Chansky M, Krishnan-Sarin S, Goniewicz ML. Nicotine Tob Res. 2023 Jan 1. PMID: 35896127.
• 'Ice' flavoured e-cigarette use among young adults.Leventhal A, Dai H, Barrington-Trimis J, Sussman S. Tob Control. 2023 Jan; 2021 Jun 14. PMID: 34127549.
• Dual Use of Combustible Cigarettes and E-cigarettes: a Narrative Review of Current Evidence.Coleman SRM, Piper ME, Byron MJ, Bold KW. Curr Addict Rep. 2022 Dec; 2022 Oct 17. PMID: 36467719.
• The Modified Cigarette Evaluation Questionnaire: Psychometric properties of the originally-proposed five-factor structure and a novel four-factor structure for use with adults who currently smoke cigarettes.Morean ME, Bold KW. Drug Alcohol Depend. 2022 Dec 1; 2022 Nov 4. PMID: 36371995.
• Examining associations of e-cigarette flavour restrictions with e-cigarette use and success quitting smoking among US adults.Bold KW, Krishnan-Sarin S, O'Malley S, Morean ME. Tob Control. 2022 Nov. PMID: 36328465.
• Curiosity, use, and perceptions of "tobacco-free nicotine" E-cigarettes among U.S. young adults.Camenga DR, Krishnan-Sarin S, Davis DR, Bold KW, Kong G, Morean ME. Prev Med. 2022 Nov; 2022 Oct 7. PMID: 36216122.
• Association of youth impulsivity and use of e-cigarette devices, flavors, and frequency of use.Davis DR, Bold KW, Morean ME, Kong G, Jackson A, Simon P, Rajesh-Kumar L, Krishnan-Sarin S. Addict Behav. 2022 Nov; 2022 Jun 9. PMID: 35809413.
• Prognostic Value of Selected Histologic Features for Lung Squamous Cell Carcinoma.Fan J, DeFina SM, Wang H. Explor Res Hypothesis Med. 2022 Sep; 2022 Mar 16. PMID: 36247021.
• Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research.Benowitz NL, Goniewicz ML, Halpern-Felsher B, Krishnan-Sarin S, Ling PM, O'Connor RJ, Pentz MA, Robertson RM, Bhatnagar A. Lancet Respir Med. 2022 Sep; 2022 Aug 16. PMID: 35985357.
• Urgent Need for Novel Investigations of Treatments to Quit E-cigarettes: Findings from a Systematic Review.Palmer AM, Price SN, Foster MG, Sanford BT, Fucito LM, Toll BA. Cancer Prev Res (Phila). 2022 Sep 1. PMID: 35816038.
• The Modified E-Cigarette Evaluation Questionnaire: Psychometric Evaluation of an Adapted Version of the Modified Cigarette Evaluation Questionnaire for Use With Adults Who Use Electronic Nicotine Delivery Systems.Morean ME, Bold KW. Nicotine Tob Res. 2022 Aug 6. PMID: 35271732.
• Longitudinal associations between flavored tobacco use and tobacco product cessation in a national sample of adults.Steeger CM, Harlow AF, Barrington-Trimis JL, Simon P, Hill KG, Leventhal AM. Prev Med. 2022 Aug; 2022 Jul 5. PMID: 35803351.
• Cigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions.Fucito LM, Bold KW, Cannon S, Serrantino A, Marrero R, O'Malley SS. Int J Environ Res Public Health. 2022 Jul 6; 2022 Jul 6. PMID: 35886090.
• Examining the potential role of e-cigarettes to reduce health disparities associated with menthol cigarette use: Characterizing e-cigarette use, flavors, and reasons for use among US adults smoking menthol cigarettes.Bold KW, Buta E, Simon P, Gueorguieva R, Jackson A, Suttiratana SC, Krishnan-Sarin S, O'Malley SS. Drug Alcohol Depend. 2022 Jul 1; 2022 Apr 27. PMID: 35594642.
• Synthetic Cooling Agents in US-marketed E-cigarette Refill Liquids and Popular Disposable E-cigarettes: Chemical Analysis and Risk Assessment.Jabba SV, Erythropel HC, Torres DG, Delgado LA, Woodrow JG, Anastas PT, Zimmerman JB, Jordt SE. Nicotine Tob Res. 2022 Jun 15. PMID: 35167696.
• Novel Nicotine Concentration Labels Improve Adolescents' and Young Adults' Understanding of the Nicotine Strength of Electronic Nicotine Delivery System Products.Morean ME, Wackowski OA, Eissenberg T, Delnevo CD, Krishnan-Sarin S, Gueorguieva R. Nicotine Tob Res. 2022 Jun 15. PMID: 35137219.
• Genotypic Differences in the Effects of Menthol on Nicotine Intake and Preference in Mice.Akinola LS, Rahman Y, Ondo O, Gonzales J, Bagdas D, Jackson A, Davidson-Wert N, Damaj MI. Front Neurosci. 2022; 2022 Jun 13. PMID: 35769694.
• Does it come from tobacco? Young adults' interpretations of the term "tobacco-free nicotine" in a cross-sectional national survey sample.Morean ME, Bold KW, Davis DR, Kong G, Krishnan-Sarin S, Camenga DR. PLoS One. 2022; 2022 May 13. PMID: 35559988.
• Cannabis use among youth who vape nicotine E-cigarettes: A qualitative analysis.Davis DR, Bold KW, Kong G, Cavallo DA, Jackson A, Krishnan-Sarin S. Drug Alcohol Depend. 2022 May 1; 2022 Mar 19. PMID: 35339972.
• Cholinergic and dopaminergic-mediated motivated behavior in healthy states and in substance use and mood disorders.Nunes EJ, Kebede N, Bagdas D, Addy NA. J Exp Anal Behav. 2022 May; 2022 Mar 14. PMID: 35286712.
• Plasma Menthol Glucuronide as a Biomarker for the Behavioral Effects of Menthol and Nicotine in Humans.Gueorguieva R, Schwartz EKC, MacLean RR, DeVito EE, Eid T, Wu R, O'Malley SS, Sofuoglu M. Front Pharmacol. 2022; 2022 Mar 31. PMID: 35431934.
• Evaluation of Flavor Effects on Oral Nicotine Liking and/or Disliking Using the Taste Reactivity Test in Rats.Bagdas D, Rupprecht LE, Nunes EJ, Schillinger E, Immanuel JJ, Addy NA. Nicotine Tob Res. 2022 Mar 26. PMID: 34918123.
• Psychometric Evaluation of the Short-Form Vaping Consequences Questionnaire for Use With High School Adolescents Who Use and Do Not Use E-cigarettes.Morean ME, Davis DR, Bold KW, Kong G, Jackson A, Lee J, Rajesh Kumar L, Krishnan-Sarin S. Nicotine Tob Res. 2022 Mar 26. PMID: 34791432.
• Longitudinal Trajectories of Multiple Nicotine Product Use Among Youths in the Population Assessment of Tobacco and Health Study.Simon P, Jiang Y, Buta E, Sartor CE, Krishnan-Sarin S, Gueorguieva R. JAMA Netw Open. 2022 Mar 1; 2022 Mar 1. PMID: 35319763.
• Impact of delivery rate on the acute response to intravenous nicotine: A human laboratory study with implications for regulatory science.De Aquino JP, MacLean RR, Gueorguieva R, DeVito EE, Eid T, Sofuoglu M. Addict Biol. 2022 Mar. PMID: 35229960.
• E-cigarette device type and combustible tobacco use: Results from a pooled analysis of 10,482 youth.Kong G, Chaffee BW, Wu R, Krishnan-Sarin S, Liu F, Leventhal AM, McConnell R, Barrington-Trimis J. Drug Alcohol Depend. 2022 Mar 1; 2022 Jan 11. PMID: 35063841.
• Balancing Risks and Benefits of E-Cigarettes in the Real World.Cohen JE, Krishnan-Sarin S, Eissenberg T, Gould TJ, Berman ML, Bhatnagar A, Barnett TE, Soule E, Popova L, Tan ASL, Blank MD, Ling PM, O'Connor R. Am J Public Health. 2022 Feb. PMID: 35080942.
• School-based E-cigarette cessation programs: What do youth want?Bold K, Kong G, Cavallo D, Davis D, Jackson A, Krishnan-Sarin S. Addict Behav. 2022 Feb; 2021 Oct 28. PMID: 34753093.
• Animal Models to Investigate the Impact of Flavors on Nicotine Addiction and Dependence.Bagdas D, Kebede N, Zepei AM, Harris L, Minanov K, Picciotto MR, Addy NA. Curr Neuropharmacol. 2022. PMID: 35611777.
• E-cigarette use and adverse respiratory symptoms among adolescents and Young adults in the United States.Chaffee BW, Barrington-Trimis J, Liu F, Wu R, McConnell R, Krishnan-Sarin S, Leventhal AM, Kong G. Prev Med. 2021 Dec; 2021 Aug 19. PMID: 34418439.
• The effects of inhaled flavors on intravenous nicotine.MacLean RR, Gueorguieva R, DeVito EE, Peltier MR, Parida S, Sofuoglu M. Exp Clin Psychopharmacol. 2021 Dec; 2020 May 28. PMID: 32463279.
• Demographic and substance use-related differences among high school adolescents who vape cannabis versus use other cannabis modalities.Morean ME, Davis DR, Kong G, Bold KW, Camenga DR, Suttiratana S, Lee J, Rajeshkumar L, Krishnan-Sarin S. Drug Alcohol Depend. 2021 Nov 1; 2021 Sep 27. PMID: 34607191.
• State marijuana policies and vaping associated lung injuries in the US.Friedman AS, Morean ME. Drug Alcohol Depend. 2021 Nov 1; 2021 Sep 22. PMID: 34600265.
• Characteristics of Registered Clinical Trials Evaluating the Role of e-Cigarettes in Cessation or Reduction of Cigarette Smoking.Hung F, Wallach JD, O'Malley SS, Bold KW. JAMA Psychiatry. 2021 Nov 1. PMID: 34468716.
• Acute effects of inhaled menthol on cognitive effects of intravenous nicotine among young adult cigarette smokers.Jao NC, Gueorguieva R, Hitsman B, Sofuoglu M. Addict Behav. 2021 Nov; 2021 Jun 18. PMID: 34174551.
• Who, me? Optimism bias about US teenagers' ability to quit vaping.Strombotne K, Sindelar J, Buckell J. Addiction. 2021 Nov; 2021 May 8. PMID: 33891783.
• Pilot Ecological Momentary Assessment Study of Subjective and Contextual Factors Surrounding E-Cigarette and Combustible Tobacco Product Use among Young Adults.Camenga DR, Haeny AM, Krishnan-Sarin S, O'Malley SS, Bold KW. Int J Environ Res Public Health. 2021 Oct 20; 2021 Oct 20. PMID: 34769525.
• Examining Menthol Preference as a Correlate of Change in Cigarette Smoking Behavior over a One-Year Period.Davis DR, Parker MA, Delnevo CD, Villanti AC. Int J Environ Res Public Health. 2021 Oct 16; 2021 Oct 16. PMID: 34682624.
• Cooling e-cigarette flavors and the association with e-cigarette use among a sample of high school students.Davis DR, Morean ME, Bold KW, Camenga D, Kong G, Jackson A, Simon P, Krishnan-Sarin S. PLoS One. 2021; 2021 Sep 1. PMID: 34469460.
• Use and perceptions of electronic nicotine delivery systems among patients attending lung cancer screening who smoke.Fucito LM, Bold KW, Baldassarri SR, LaVigne JP, Ford B, Sather P, O'Malley SS, Toll BA. Prev Med Rep. 2021 Sep; 2021 Jun 9. PMID: 34235048.
• Adults who use e-cigarettes have difficulty understanding nicotine concentrations presented as mg/ml and percent nicotine.Morean ME, Wackowski OA, Eissenberg T, Delnevo CD, Krishnan-Sarin S. Addict Behav. 2021 Sep; 2021 Apr 27. PMID: 34022756.
• An ongoing saga of nicotine complexity and dopamine heterogeneity: Nicotine activation and inhibition mediating reward and anxiety.Addy NA. Neuron. 2021 Aug 18. PMID: 34411537.
• Adolescents and Young Adults Have Difficulty Understanding Nicotine Concentration Labels on Vaping Products Presented as mg/mL and Percent Nicotine.Morean ME, Wackowski OA, Eissenberg T, Delnevo CD, Krishnan-Sarin S. Nicotine Tob Res. 2021 Aug 4. PMID: 33433626.
• Association of Vaping and Respiratory Health among Youth in the Population Assessment of Tobacco and Health (PATH) Study Wave 3.Cherian C, Buta E, Simon P, Gueorguieva R, Krishnan-Sarin S. Int J Environ Res Public Health. 2021 Aug 3; 2021 Aug 3. PMID: 34360499.